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ABSTRACT
Recent studies indicate that the DNA recognition
domain of transcription activator-like (TAL) effect-
ors can be combined with the nuclease domain of
FokI restriction enzyme to produce TAL effector nu-
cleases (TALENs) that, in pairs, bind adjacent DNA
target sites and produce double-strand breaks
between the target sequences, stimulating non-
homologous end-joining and homologous recom-
bination. Here, we exploit the four prevalent TAL
repeats and their DNA recognition cipher to
develop a ‘modular assembly’ method for rapid pro-
duction of designer TALENs (dTALENs) that recog-
nize unique DNA sequence up to 23 bases in any
gene. We have used this approach to engineer
10 dTALENs to target specific loci in native yeast
chromosomal genes. All dTALENs produced high
rates of site-specific gene disruptions and created
strains with expected mutant phenotypes.
Moreover, dTALENs stimulated high rates (up to
34%) of gene replacement by homologous recom-
bination. Finally, dTALENs caused no detectable
cytotoxicity and minimal levels of undesired
genetic mutations in the treated yeast strains.
These studies expand the realm of verified TALEN
activity from cultured human cells to an intact eu-
karyotic organism and suggest that low-cost, highly
dependable dTALENs can assume a significant role
for gene modifications of value in human and animal
health, agriculture and industry.
INTRODUCTION
Technologies for precise and efﬁcient gene editing in living
cells hold great promise in both basic and applied
research, including therapeutic interventions for genetic
diseases. These technologies exploit the ability of endo-
nucleases to cause chromosomal double-stranded DNA
breaks (DSBs) and stimulate the subsequent breakage
repair mechanisms in living cells (1–3). The two widely
conserved, major repair pathways in eukaryotes are
non-homologous end-joining (NHEJ) and homologous re-
combination (HR). NHEJ repair often results in mutagen-
ic deletions/insertions and substitutions in the targeted
gene. DSBs also stimulate HR between the endogenous
target gene locus and an exogenously introduced homolo-
gous donor DNA carrying desired genetic alterations
(4–6). At the forefront of these methods are custom-
designed zinc-ﬁnger nucleases (ZFNs), which are hybrid
proteins derived from the DNA binding domains of zinc-
ﬁnger (ZF) proteins and the non-speciﬁc cleavage domain
of the endonuclease FokI. However, despite their promise,
widespread adoption of ZFNs is hampered by a bottle-
neck in custom-engineering ZFs with high speciﬁcity and
afﬁnity for the DNA target sites (7,8). Further, ZFN
utility is somewhat limited by the number and location of
potential target sites within a genome. Alternative strate-
gies that overcome limitations in current technologies for
targeted genome editing could greatly accelerate adoption
of artiﬁcial nucleases for efﬁcient gene disruption and
gene replacement in a variety of heretofore recalcitrant
eukaryotic organisms.
ZFN efﬁcacy depends almost solely on the DNA
binding speciﬁcity of their ZF domains (9), which theor-
etically can be supplanted by any high-ﬁdelity DNA
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fector (TALE) proteins, a large group of bacterial plant
pathogen proteins, have emerged as alternatives to ZF
proteins. TALE proteins contain a varying number of cen-
trally located tandem 34-amino-acid repeats that mediate
binding to a speciﬁc DNA target sequence, referred to as
the effector binding elements (EBE). Each repeat is nearly
identical except for two variable amino acids at positions
12 and 13, known as repeat variable di-residues (RVD).
Polymorphism in the number of repeats (a range of 13–33)
and in the RVD composition collectively determines the
DNA binding speciﬁcity of individual TALE proteins.
Remarkably, recognition of a speciﬁc DNA sequence is
based on a fairly simple code wherein one base of the
DNA target site is recognized by the RVD of one repeat
(i.e. one repeat/one nucleotide). The sequential repeat ar-
rangement in a single TALE protein thus speciﬁes the
contiguous DNA sequence that will be bound by that
TALE protein (13,14). TALE recognition studies also
reveal a preference for certain RVDs over others in reco-
gnizing a particular nucleotide. In most cases, the RVDs
asparagine and isoleucine (NI), histidine and aspartic acid
(HD), asparagine and glycine (NG) and two asparagines
(NN) combine to recognize the nucleotides ‘A’, ‘C’, ‘T’
and ‘G’, respectively (13,14). The prevalence of these
four RVDs in the native TALEs made it possible to use
them exclusively to de novo synthesize or assemble TALE
repeat arrays of up to 13 repeat units to target DNA se-
quences in plant and human cells (15–17). The addition of
FokI nuclease domains to the C-termini of two paired
synthetic TAL effectors (as in ZFNs) should allow for
highly gene-speciﬁc gene targeting. Because of the
modular nature of TALEs and the potential to use long
DNA recognition sites, custom-made designer TALE nu-
cleases (dTALENs) may overcome limitations of current
ZFN technologies and may signiﬁcantly advance the use
of targeted genome editing for challenging long-term
opportunities such as therapeutic repair of genetic
diseases. Toward this end, we and others have recently
shown that TALEs can be linked with FokI nuclease
domain to direct targeted cleavage of DNA containing a
speciﬁc EBE (17–19). More recently, Miller et al. (20)
demonstrated TALEN-mediated editing of endogenous
genes in cultured human cells.
Here, we report development of a modular assembly
technology for custom-engineering dTALENs and charac-
terization of 10 such dTALENs for targeted gene modiﬁ-
cation. The method uses four basic repeats with RVDs of
NI, NG, NN and HD to generate 48 ready-to-use modules
of single-TAL repeat units that can be used to assemble up
to 23 repeat units in any predetermined order. The
modular assembly method is simple, fast and inexpensive
and can be performed in most academic or industrial mo-
lecular biology laboratories. Remarkably, all 10 dTALENs
demonstrated efﬁcient gene knockout and/or gene replace-
ment in tests with three different chromosomal genes in
yeast (Saccharomyces cerevisiae). The high success rate
and facile synthesis of potent dTALENs against a variety
of chromosomal targets further establishes dTALENs as
an emerging and viable technology for precise gene modi-
ﬁcation in living cells. As previously practiced, all materials
described in the present study will be provided to other
laboratories upon request.
MATERIALS AND METHODS
Yeast strains and growth conditions
Yeast strains YPH499, YPH500 and RFY231 as previous-
ly described (18,21) were grown in nutrient medium YPD
or synthetic complete medium (SC) lacking the appropri-
ate nutrients. 5-ﬂuoroorotic acid (5-FOA) was used at
0.1% in SC medium as described (22). a-aminoadipate
(a-AA) was used at 0.2% in SC medium lacking the
normal nitrogen source, but containing a small amount
of lysine (30mg/l) (23). The adenine limited medium is
SC medium containing a limited amount of adenine
(10mg/l) and lacking leucine and histidine (24).
dTALEN constructs
Four repeats, each encoding the RVD of NI, NG, HD or
NN from AvrXa7, were used as the ‘core’ repeats. [More
recently, NK has been substituted for NN in the recogni-
tion of G nucleotides based on the observations of
Miller et al. (20).] Using a combination of 12 forward
and 11 reverse primers (Supplementary Table S1), 12
repeat sets were constructed from the 4 ‘core’ repeats.
For construction of the ﬁrst 8–mer repeat array, combin-
ations of the PCR primers were: TAL-Sph-F and
TALcgct-R, TALcgct-F and TALcctt-R, TALcctt-F
and TALctct-R, TALctct-F and TALcgtt-R, TALcgtt-F
and TALcttt-R, TALcttt-F and TALcatt-R, TALcatt-F and
TALccct-R and TALccct-F and TAL/Pst-R for repeat Set
1–8, respectively. For ligation of the second and the third
8–mer repeat arrays, two additional repeat sets each cor-
responding to Set 1 were constructed by using primers
TAL/Pst-F&TALcctt-R and TAL/Bsr-F&TALcctt-R, re-
spectively; another two repeat sets corresponding to Set 8
were also constructed by using primers TALccct-R and
TAL/Bsr-R, and Tailcact-F&TAL-Sph-R, respectively.
In total 12 repeat sets were generated and then individu-
ally digested with BsmBI. Based on the base entity and
order of the preselected target DNA sequence (e.g. any
sequence combination of 22bp long), one repeat from
each of eight repeat sets was sequentially selected for
one ligation reaction to construct the 8–mer repeat
array. Each set of ligated DNA was directly cloned into
pGEM-T for sequencing. Once conﬁrmed, the ﬁrst 8–mer
array was digested with SphI and PstI, the second 8–mers
with PstI and BsrGI, and the third array with BsrGI and
SalI. The three puriﬁed DNA fragments were ligated into
pSK/AvrXa7 (18) that was digested with SphI and SalI,
resulting in pSK/dTALE plasmids. The repeat regions of
individual dTALEs were used to replace the TALE repeat
domain of AvrXa7 in pCP3M-AvrXa7-FN or pCP4M-
AvrXa7-FN (18), resulting in chimeric genes encoding
the fusion of the full-length dTALE and the C-terminal
FokI homodimeric cleavage domain. The expression level
of these nuclease genes should be moderate due to the low
copy number (about one copy per cell) of the centromeric
plasmids pCP3M and pCP4M and the strong promoter
from the translation elongation factor 1 a gene (25).
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The individual target sites were constructed into pCP5
(18) in a tail-to-tail (30 to 30) orientation with AvrXa7
EBE. The oligonucleotide sequences for all TALEN
EBEs were provided in Supplementary Table S2.
AvrXa7 EBE ( 7-EBE-F&R) was cloned into the PstI
and SpeI sites of pCP5. The EcoRI site immediately
upstream of SpeI site enabled all other TALEN EBEs to
be cloned individually between EcoRI and SpeI sites, re-
sulting in the reporter plasmids for individual TALENs in
combination with AvrXa7-FN. The assay for each indi-
vidual TALEN paired with AvrXa7-FN was performed in
a manner similar to that described (18). The assays were
performed in triplicate.
Targeted gene disruption of URA3, LYS2 and ADE2
in yeast
The URA3 gene (ura3–52) that was insertionally inacti-
vated by the transposon, Ty1, in YPH500 was restored
to a functional URA3, resulting in strain YPH500a.
Similarly, the target sequences for ZFNs (Zif268 and
BCR-ABL) and for TALENs of AvrXa7 and PthXo1
were individually integrated into the URA3 gene immedi-
ately downstream of the start codon and used to restore
the ura3-52 mutant, resulting in strain YPH500b and
YPH500c, respectively. YPH500b was transformed with
plasmids pCP3M/Zif268-FN and pCP4M/BCR-ABL-
FN. DNA fragment for the ZF protein Zif268 was PCR
ampliﬁed from pMal-Zif268 (kindly provided by David J.
Segal) using primers Zif268-F and Zif268-R and cloned in
frame with FokI cleavage domain in pCP3M. Construct
pCP4M/BCR-ABL-FN was described previously (18).
YPH500c was transformed with pCP3M/AvrXa7-FN
and pCP4M/PthXo1-FN, two plasmids previously de-
scribed (18). YPH500a was transformed with plasmids ex-
pressing the paired dTALENs U3a_L and U3a_R and
U3b_L and U3b_R. The respective yeast strains
were transformed with plasmids pCP3M and pCP4M as
a negative control for each paired nucleases. The trans-
formants were grown on SC medium lacking histidine and
leucine for 5 days before plating on the SC medium con-
taining 0.1% 5-FOA for selection of resistant colonies and
in parallel on SC medium without 5-FOA to test for
plating efﬁciency. Genomic DNA extracted from a
number of 5-FOA-resistant colonies for each pair of nu-
cleases was used for PCR ampliﬁcation of the relevant
regions. The PCR products were sequenced using the re-
spective primers. Similarly, gene disruption of LYS2 and
ADE2 was performed in yeast strain RFY231. See
Supplementary Data for detailed information regarding
the creation of these strains and gene disruption.
HR-based URA3 gene replacement stimulated
by dTALENs
Donor DNA constructs were made each with the ORF
of URA3 deleted (pura3) and replaced by the NPTII
expression cassette (pura3::Kan). YPH500c was trans-
formed with the donor construct and a plasmid expressing
the TALEN pair AvrXa7-FN and PthXo1-FN, dTALENs
U3a-L and -R, U3b-L and -R, or with the plasmids lacking
a nuclease gene as control. The transformed cells were
grown in SC media lacking histidine and leucine for
5 days, then plated on SC medium supplemented with
either 5-FOA (for pura3) or YPD medium supplemented
with 200mg/l of G418 (for pura3::Kan), the duplicated
cellswereinparallelplatedonSCmediumorYPDmedium
to determine plating efﬁciency. See Supplementary Data
for additional details.
Cell growth assay
YPH500 cells were transformed with individual plasmids
as indicated in the text. Three single colonies for each plas-
mid were picked and grown to a concentration of
OD600=1.0. The cells were serially diluted and applied
to appropriate solid medium for growth, which was
observed daily for 5 days.
Solexa sequencing and data analysis
The genomic DNA from each of ﬁve yeast strains derived
from YPH500, which is congenic with S288C (26), was ex-
tracted as described by Philippsen et al. (27). The DNA
processing and sequencing were performed according to
manufacturer’s instruction for the Illumina/Solexa
Genome Analyzer II at the Iowa State University DNA
facility. The Illumina short reads for each strain were
aligned to the yeast reference genome S288C to assemble
each genome using the BWA software (28). The consensus
sequences and polymorphisms among the ﬁve sequenced
strains and S288C were delineated using SAMtools (29).
RESULTS
Tractability of yeast for testing gene modiﬁcation by
TALENs
We chose yeast, a classic eukaryotic model for studies of
HR (30), as a platform to develop and test TALEN-based
technologies for targeted gene modiﬁcation based on the
recent breakthroughs in the area of TALE research
(13,14,17,18). First, we determined if the yeast chromo-
some, which has not been subjected to genome modiﬁca-
tion using any artiﬁcial nucleases, is tractable for TALE
nuclease-based modiﬁcation. For this experiment, the
EBEs for AvrXa7 and PthXo1 were precisely integrated
in-frame between the ﬁrst and second codons of the yeast
URA3 gene on chromosome 5. In parallel, DNA target
sequences for the known ZFNs Zif268 and BCR-ABL
were inserted into the identical URA3 gene site for com-
parison of activities conferred by these two types of nu-
cleases (Figure 1 and Supplementary Figure S2). The
resulting yeast strains were prototrophic in uracil-free
medium and sensitive to 5-FOA, indicating that the
chimeric URA3 genes were functional and intact. Yeast
strains bearing the chimeric URA3 genes were trans-
formed with plasmids expressing the paired TALENs or
ZFNs, grown for 5 days, plated on medium containing
5-FOA to select cells with an inactivated URA3 gene.
Approximately 0.9% of cells (out of  10
6 cells) expressing
paired TALENs produced 5-FOA resistant colonies while
Nucleic Acids Research, 2011,Vol.39, No. 14 6317 0.3% of cells expressing paired ZFNs yielded 5-FOA
resistant colonies. In contrast, no 5-FOA resistant
colonies were observed among  10
6 cells containing
plasmids lacking a functional nuclease gene (a ratio of
<0.0001%). Sequenced PCR products from the relevant
alleles revealed all of the selected 5-FOA-resistant clones
harbor mutations (insertions and/or deletions that caused
frame shift in the URA3 genes) at the nuclease target sites
(Figure 1 and Supplementary Figure S2). These results
established similar gene disruptions and comparable
mutation rates elicited by ZFNs and TALENs targeted
against genes in a native yeast chromosomal environment.
Modular dTALEN assembly
To fully realize the potential of TALENs, they must be
custom-engineered to target any chromosomal DNA
sequence of interest. By exploiting the repeat homology
and the unique recognition sequence of the type IIS re-
striction enzyme BsmBI within each repeat of AvrXa7 or
any TALE, we developed a method to assemble repeat
domains in an exact predetermined order to recognize a
speciﬁc DNA sequence in any gene of choice from any
organism. Brieﬂy, four AvrXa7 ‘core’ repeats whose
coding RVDs each recognize one of four nucleotides (i.e.
NI, NG, NN and HD, respectively, for A, T, G and C)
were used to construct independent modules (single
repeats) whose 50- and 30-ends were designed to form a
unique 4-bp overhang with single-base polymorphism
after digestion with BsmBI. The BsmBI site is immediately
downstream of codons 18 and 19 of each repeat and
BsmBI cleaves these two triplets into a 50 overhang of
4-bp at each end. The 18th and 19th codons are GCG
CTG and can be modiﬁed into eight variant triplets
GC(A, T, G or C) (T or C) TG (Figure 2A). Therefore,
combinations of eight or fewer such overhangs, one at
each end of a single repeat, were created without altering
the encoded amino acids. This allowed the ordered ligation
of eight or fewer repeat modules in any predetermined
sequence for construction of sub-arrays of repeats
(Figure 2B). Each sub-array was cloned into the cloning
vector pGEM-T and sequenced to conﬁrm the correct
number and order of the repeats. Similarly, multiple
sub-arrays (two and three in this study) were further
assembled to match the order of nucleotides at the prese-
lected genomic site. The AvrXa7-FN nuclease (18) lacking
its repeat domain was used as the scaffold for the
assembled repeat domains, resulting in a ﬁnished
dTALENs (Figure 2C).
To test the feasibility of our approach, we selected ﬁve
distinct dual target sites (two in URA3, two in LYS2 and
Figure 1. DNA alterations by natural TAL effector-derived TALENs at chromosomally integrated paired EBE target sites in the URA3 gene.
(A) Schematic of TALENs used in the study. Full-length TALEs were fused with the homodimeric cleavage domain of FokI (FN). The number of
amino acids in the separate domains is shown above each region (NLS, nuclear localization motifs; AD, transcription activation domain). (B) Target
sequences between the ﬁrst and second codons of the yeast URA3 gene targeted for cleavage by hybrid TALENs derived from AvrXa7 and PthXo1.
(C) Alignment of genomic sequences of mutants and their parental strain at the TALEN target site. The number of nucleotides inserted (lowercase
letters in red) or deleted (dashes) compared to parental sequences (PT) from each mutant colony is indicated on the right of each sequence.
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target sequence; (ii) avoiding G-rich blocks; and (iii) 17–
20bp spacer between the two inverted EBE target sites.
Accordingly, 10 dTALENs were synthesized for gene tar-
geting based on the preselected DNA coding sequences of
the three yeast genes (Figure 3A). All 10 dTALENs were
expressed in yeast to levels comparable to those of hybrid
nucleases made from PthXo1 or AvrXa7, except U3b-L
which had somewhat lower expression (Supplementary
Figure S3).
To test the function of newly synthesized dTALENs
and to reveal their relative DNA cleavage activity, we
modiﬁed a transient and plasmid-borne single-strand
annealing (SSA) assay (31,32) as a facile analytical tool.
This method uses a yeast plasmid carrying a lacZ gene
divided into upstream and downstream portions by inser-
tion of two opposing EBEs, one recognized by a proven
AvrXa7 TALEN (18) and the other EBE recognized by a
candidate dTALEN. The separated lacZ fragments share
at the 30-end of the upstream fragment and the 50-end of
the downstream fragment a 125bp segment of identical
lacZ sequence. If a functional dTALEN is co-expressed
in yeast cells with the AvrXa7 TALEN along with the
target lacZ gene, it will bind to its target EBE sequence
adjacent to the AvrXa7 TALEN and, thereby, create a
DSB (Figure 3B). The duplicated lacZ sequences are
thus available for HR and restoration of an intact lacZ
gene. The amount of b-galactosidase activity produced by
Figure 2. Design and modular construction of dTALENs. (A) TALEN repeat gene sets for modular construction of multi-repeat TALEN genes.
Each set contains four single-repeat genes each encoding one of the four ‘core’ TALEN repeat modules containing NI, NG, NN and HD RVDs with
binding speciﬁcity for A, T, G and C nucleotides, respectively. The core repeats in each set (boxed) contains a 50- and 30-termini unique to that
particular set—as listed in the inset table. For construction of a TALEN repeat array recognizing a speciﬁc 8nt DNA recognition sequence (e.g.
AGGTACTC), an NI repeat gene is selected from Set 1, an NN repeat gene from Set 2, an NN repeat gene from Set 3, an NG repeat gene from Set
4, etc. The 50- and 30-terminal regions are designed such that BsmBI digestion results in generation of 50 and 30 4-base overhangs. Because of the
unique complementarity of 30 overhangs from Set 1 genes with the 50 overhang of genes from Set 2, the complementarity of the 30 overhangs of Set 2
with 50 overhangs from Set 3, etc., the annealing and ligation of overhangs results in one, and only one, ordered alignment of the eight repeat genes
that, when translated, will speciﬁcally recognize and bind (in the present example) the AGGTACTC DNA recognition sequence. (B) Once two (or
three) such blocks of repeats are constructed, they are combined in a similar ordered fashion to create a TALE repeat region that is capable of
binding a speciﬁc 16 (or 24) bp target site. (C) The assembled TALE repeat domains are cloned into the TALEN repeat-deﬁcient pAvrXa7-FN
scaffold to create a candidate dTALEN.
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amount of DNA cleavage supported by the candidate
dTALEN. We initially tested this assay by ﬁrst pairing
the proven AvrXa7-FN TALEN with another proven
TALEN, PthXo1-FN (18). The activity of this TALEN
pair provides a standard against which the activity of
any candidate dTALEN can be judged (Figure 3C). The
10 newly produced dTALENs, each designed to recognize
a speciﬁc 17–23 base DNA sequence in different yeast
genes, were all found in the yeast SSA tests to function
nearly as well or better than the standard AvrXa7/PthXo1
TALEN pair (Figure 3C).
Efﬁcient gene modiﬁcation by dTALEN-induced NHEJ
and HR
As a ﬁnal evaluation of the function of the ﬁve pairs of
dTALENs, we tested their ability to elicit site-speciﬁc
DNA alterations at the preselected target sites in the
URA3, LYS2 and ADE2 genes, which all have easily
scored knock-out phenotypes. Yeast cells were trans-
formed with individual pairs of dTALEN-expressing
plasmids and grown for 5 days on SC medium to allow
accumulation and activity of the heteromeric dTALEN
pair. Two yeast cultures were transformed separately
with one or the other pair of dTALENs targeting the
URA3 gene and plated for 5-FOA selection of cells
lacking a functional URA3 gene. Likewise, two yeast
cultures were transformed separately with one or the
other pair of dTALENs targeting the LYS2 gene and
plated for a-aminoadipate (a-AA) selection of cells with
LYS2 gene mutations. URA3 and LYS2 mutants were
obtained at a rate of  10
 4 to 10
 2 mutants/total cells
(Figure 4A). Yeast cells transformed with the dTALENs
pair targeting the ADE2 gene were plated on medium con-
taining limiting adenine concentrations that result in the
formation of pink colonies if a functional ADE2 gene is
not present. Pink colonies appeared with a frequency of
0.15% (Figure 4A). In contrast,  10
6 yeast cells carrying
Figure 3. Yeast SSA assay of modularly assembled dTALENs targeting three endogenous yeast genes. (A) RVD sequences within repeat modules of
10 custom-synthesized dTALENs. N* represents dTALEN repeat modules with the 13th amino acid missing. (B) Schematic of the yeast SSA assay
for measuring dTALEN activity based on plasmid-borne HR. Individual candidate dTALENs are assayed in combination with AvrXa7-FN for their
ability to stimulate the recombination between the duplicated regions of LacZ gene (hatched boxes), leading to formation of a functional lacZ gene.
(C) Activities of individual dTALENs in creating DSBs as detected in a b-galactosidase assay. Control denotes the b-galactosidase activity (<5U)of
yeast cells lacking a functional TALEN gene. Error bars denote SD; n=3.
6320 Nucleic Acids Research, 2011,Vol.39, No. 14plasmids lacking a functional dTALEN gene pair yielded
no colonies resistant to 5-FOA or a-AA or with a pink
color. Sequence analysis of PCR-ampliﬁed genomic DNA
from the relevant target sites in several putative URA3,
LYS2 and ADE2-gene knock-out mutants revealed that
all alleles harboured mutations at the dTALEN target
sites as expected. A high proportion of the mutated loci
contained deletions in a range from 1 to 75bp (Figure 4B
and Supplementary Figure S4).
One experimentally and practically important virtue of
DSBs caused by agents such as ZFNs (3) is that they
increase rates of recombination between the DNA se-
quences within a broken gene and homologous endogen-
ous or exogenously-supplied DNA sequences, which
enables powerful gene replacement research opportunities.
To determine if dTALEN-mediated DSBs stimulate HR,
we targeted the URA3 gene for breakage with artiﬁcial
dTALEN pairs in the presence of two different exogen-
ously supplied DNA fragments, one containing a URA3
gene interrupted by a neomycin phosphotransferase II
(NPTII) expression cassette and the other a DNA
fragment with the URA3 ORF deleted. Both fragments
Figure 4. dTALEN-induced gene modiﬁcations by NHEJ and HR. (A) The frequency of gene disruption induced by ﬁve sets of paired dTALENs at
ﬁve speciﬁc gene target sites as measured by the numbers of colonies with the indicated mutant phenotypes. ‘—’ denotes not applicable. (B)
TALEN-induced insertion/deletion mutations at three of ﬁve gene loci tested. (Mutations at the other two target sites are provided in
Supplementary Figure S4.) Genomic sequences from each mutant clone at the relevant loci are aligned with the respective wild-type sequences.
dTALEN target sites are underlined. The number of nucleotides inserted (bold uppercase letters) or deleted (dashes) is indicated to the right of each
sequence. (C) TALEN-induced HR as measured by the percentage of yeast colonies displaying the indicated phenotypes.
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the 50 end of the URA3 gene and, at their 30 ends, a 0.2kb
segment from the 30 end of the URA3 gene. Yeast cells of
YPH500c, a strain containing the functional URA3 with
the integrated EBEs for AvrXa7 and PthXo1, were trans-
formed with one set of three different paired TALENs (i.e.
U3a-L and U3a-R, U3b-L and U3b-R, and AvrXa7-FN
& PthXo1-FN) and one of the two modiﬁed URA3 gene
constructs. The transformants were plated after 5 days of
incubation on either selective medium containing 5-FOA
(deleted URA3 construct) or medium containing the
neomycin-like antibiotic, G418 (NPTII interrupted
URA3). Cells transformed with TALENs and the URA3
ORF deletion construct (DURA3) showed frequencies
of 5-FOA-resistant colonies in the range of 4.5–27%.
The negative control [transformed with donor DNA and
plasmids lacking a nuclease gene (Empty Plasmid)] yielded
5-FOA-resistant colonies at a rate of 0.01% (Figure 4C).
The frequency of gene replacement for cells transformed
with the NPTII-interrupted URA3 gene construct (NPTII)
was in the range of 9–34% with the negative control
(Empty Plasmid) displaying only  0.1% gene replace-
ment activity (Figure 4C). Overall, the enhancement
of TALEN-induced gene replacement was between 100-
and 2700-fold higher than the control. The scale and con-
sistency in the stimulation of HR by dTALENs sug-
gests they have the potential to promote HR when
used in eukaryotic cells that lack other sufﬁciently
robust mechanisms to facilitate HR.
Genome-wide undesired mutations caused by TALENs
Some ZFNs have been found to be associated with
toxicity in living cells (33–39). Whether such effect also
exists for TALENs is unknown. To test the possibility,
yeast cells were transformed with plasmids encoding six
pairs of TALENs (one pair of native TALE-derived nu-
cleases and ﬁve pairs of synthetic dTALENs targeting se-
quences in a size range between 17 and 27bp) and one pair
of known ZFNs [Zif268 and BCR-ABL with target se-
quences of 9bp (33,40)]. The transformed cells were
grown in SC medium lacking leucine and histidine.
During 5 days of growth, TALEN-expressing yeast cells
displayed no distinct phenotype in terms of cell viability
and proliferation compared to the control, as did yeast
strains with ectopic expression of paired ZFNs
(Figure 5). Yeast cells expressing individually each of the
eight introduced nuclease genes showed similar results
(Supplementary Figure S6). The results indicate the lack
of any apparently deleterious effects on the viability of
yeast cells expressing the tested TALENs and ZFNs
under our experimental conditions.
Undesired genetic mutations (genotoxicity) due to pro-
miscuous cleavage also have been reported for ZFNs
(33,40,41), but it is unknown whether TALENs also
induce such genotoxicity. It is possible that such muta-
tions occurred in our cell survival experiment but did
not visibly affect the viability of the yeast cells. The
haploid nature and relatively small size ( 12Mb) of the
yeast genome in combination with the next-generation
sequencing technology enabled us to investigate any
potential genome-wide undesired effects of TALENs.
Five strains, including the parental strain YPH500 and
four mutants, were chosen to investigate the occurrence
of unintended mutations in addition to the site-speciﬁc
mutations at the URA3 locus mediated by the respective
nucleases. The four mutant strains included one that con-
tained a deletion in the chimeric URA3 gene at the
integrated EBE site targeted by the paired nucleases of
natural TAL effectors AvrXa7 and PthXo1, one that con-
tained an insertion in the chimeric URA3 gene with
integrated target sequences for the ZFNs Zif268 and
BCR-ABL, and the other two that each contained a
deletion mutation in the wild-type URA3 genes induced
by the paired dTALENs U3a-L&-R and U3b-L&-R, re-
spectively. The ﬁve strains were sequenced using Illumina/
Solexa Genome Analyzer II, and their genomes were
assembled with coverage depths [(number of reads 
average read length) / (size of genome)] in a range from
135 to 170 (sequences available upon request). The as-
sembled genomic sequence of each mutant strain was ﬁrst
screened for possible mutations at the sites that matched
or loosely matched (deﬁned as at least two-thirds of match
as the cut-off) either intended sub-dual target sequence for
the respective nucleases (Supplementary Figure S5). No
mutations were found at those locations other than the
Figure 5. Growth of yeast cells expressing the paired TALEN and
paired ZFN genes. Strains containing plasmids encoding the indicated
nuclease genes (on the left side of each row) or lack thereof (pCP3M
and pCP4M) were serially diluted (from 10
4 to 10 cells), applied as
spots to SC medium plates lacking histidine (for pCP3M and its
derived plasmids) and leucine (for pCP4M and its derived plasmids)
and allowed to grow for 4 days.
6322 Nucleic Acids Research, 2011,Vol.39, No. 14site-speciﬁc mutations mediated by the respective pairs of
TALENs and ZFNs in each genome (data not shown).
However, alignment of the genomes of the individual
nuclease treated strains with that of parental strain
revealed a few mutations in each strain (in a range from
3 to 5 mutations) (Supplementary Table S4). These muta-
tions were almost all nucleotide substitutions instead of
predominant deletions/insertions at the nuclease target
sites and they, therefore, were highly likely to be simultan-
eous mutations which might or might not be associated
with the nuclease treatment.
DISCUSSION
We have developed a simple, cost-effective method to as-
semble functional TALE DNA binding domains, combine
them with a nuclease module and conﬁrm their activity
against speciﬁc gene targets in vivo. Using this method,
dTALENs were readily produced and rapidly validated
using a facile yeast SSA assay. Importantly, these
dTALENs were then demonstrated to function as pairs
to mediate efﬁcient gene disruption by NHEJ and gene
replacement by HR at speciﬁc yeast chromosomal loci.
The DNA binding domain encoded by a TALE gene is
modular by nature, having 13–33 RDV units that bear a
simple code for target site recognition (13,14). However,
the high-repeat homology imposes technical difﬁculty
when using PCR-based de novo gene synthesis methods
(42) for construction of the lengthy repeat arrays
required for high-level DNA speciﬁcity. To simplify gene
synthesis and reduce dTALEN production costs, a
modular assembly technique was developed. TALE
repeat domains have been assembled from the single-
RVD coding repeats to bind DNA targets predicted by
the cipher; but they were assembled in a random way,
not in a predetermined order and not based on the target
DNA sequence (13). Our method involves creation of
48 ready-to-use modules and their assembly into repeat
arrays in a controlled order based on any user chosen
target DNA sequences (Figure 2). The ready-to-use mod-
ules can also be adapted for high-throughput dTALEN
synthesis. By manipulating the combination of 50 and 30
unique overhangs of the modular sets, dTALENs with
varying number of repeat units (up to 23bp in this
study) can be designed to better meet the criteria in choos-
ing the dual target sites. Our facile modular TALEN
assembly method contrasts with another recently reported
method that involves several rounds of PCR ampliﬁca-
tions and ligations to assemble individual repeats into
12 repeat TAL effectors for gene activation in human
cells (16).
A modiﬁed plasmid-based yeast SSA lacZ assay was em-
ployed to determine activity of the candidate dTALENs
before use for ﬁnal gene targeting. This test system is
based on assays developed to initially validate engineered
meganucleases and ZFNs (31,32) and was used previously
in a preliminary form for TALEN testing (17,18). The
original yeast SSA assay relied on inverted repeat DNA
targets and engineered homodimeric nucleases (32).
For our modiﬁed assay, one candidate dTALEN was
paired with the proven TALEN AvrXa7-FN (18) to
target two adjacent EBEs, one for recognition by the can-
didate dTALEN and the other for binding of AvrXa7-FN.
The paired TALENs derived from the natural TALEs
AvrXa7 and PthXo1 were used as a standard. Another
advantage of the modiﬁed SSA assay is that one EBE
and the spacer remain constant so only the second EBE
has to be replaced to test a different dTALEN. When
testing many dTALENs, this represents asigniﬁcant ( 5 )
cost saving due to using much shorter oligonucleotides
to create a single (versus double) TALEN site while
allowing rapid evaluation of the activity of each individual
candidate dTALEN. Moreover, construction of 30 to 30
EBE sites containing non-identical DNA sequences
avoids the technical challenges associated with cloning
and stably maintaining inverted EBE sites containing iden-
tical TALEN recognition sequences. From a broader per-
spective, this plasmid-based transient assay should be
readily adapted as a facile screening tool in animal and
plant cell culture systems.
The 10 dTALENs engineered for this study were de-
signed in pairs to target the native sequences of the yeast
genes, URA3, LYS2 and ADE2. Each gene has a selectable
or easily scored phenotype, so any dTALEN activity
should be readily apparent. Expression of dTALEN
pairs under appropriate selections indicated that all ﬁve
dTALEN pairs were functional in creating phenotypic
mutant strains whose site-speciﬁc DNA alterations were
all conﬁrmed by genotyping (Figure 4 and Supplementary
Figure S4). The activity of the ﬁve dTALEN pairs was
comparable to the standard TALEN pair, AvrXa7 and
PthXo1. Two pairs of dTALENs also were tested for
their ability to mediate HR by targeting URA3 for gene
replacements and compared against HR stimulated by
the standard TALEN pair. The results indicated that
dTALENs and standard TALENs increase HR at a com-
parable rate (Figure 4). The low rates of gene disruption
via NHEJ in present study are probably attributable to the
cryptic NHEJ repair pathway in yeast. The NHEJ repair
of DSBs in yeast is mostly accurate. For example, repair
to DSBs with 4-base overhangs led to an error frequency
of only  1% (43,44). Only cells with mutagenic alter-
ations in the intentionally targeted genes might be re-
covered (for URA3 and LYS2) or detected (for ADE2)
by using our procedures. Thus, while the number of
dTALENs examined was somewhat limited, these experi-
ments establish that dTALENs are active in vivo in
promoting NHEJ- and HR-mediated gene modiﬁcations
at endogenous loci in an intact, free-living, eukaryotic
organism and, thus, verify the power of TALENs for
targeted genome editing in eukaryotes beyond the
TALEN-mediated gene disruption previously
demonstrated in cultured human cells (20).
Taken together, the results of this study indicate that
the modular assembly technique is valid, that the yeast
SSA assay is a reliable and facile indicator of TALEN
activity and that functional dTALENs can target a
diverse range of genomic loci. Our study also establishes
that yeast, as an intact eukaryotic organism, is a reliable
platform to develop and potentially reﬁne engineered
nuclease-based technology for targeted genome editing.
Nucleic Acids Research, 2011,Vol.39, No. 14 6323The designer TALEN technology described here may over-
come a number of critical hurdles (e.g. high cost, limited
plasticity and high rates of failure) faced in designing and
producing other types of nucleases with DNA targeting
capabilities (7,8). The opportunity to build dTALENs
with quite long DNA recognition domains bodes well
for developing TALENs with exceptionally high accuracy
in targeting any gene in any organism, including eukary-
otes with highly complex genomes. Such technology has
signiﬁcant potential in experimental biology and medicine
and in the development of products with value for human
and animal health, agriculture and in a wide range of life
sciences industries.
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